Nelson Labs Will Present on Medical Device Sterilization at MD&M Texas
Nelson Laboratories will present "Medical Device Sterilization: Selection of Sterility Assurance Level (SAL), Evaluation of Bioburden Data, Alert and Action Levels of Bioburden Excursions" at MD&M Texas, May 7-8, 2014 at the Fort Worth Convention Center, and will be available for consultation at booth 523.
Martell Winters, senior scientist at Nelson Laboratories, will speak at a Learning Lab on May 8 from 10 a.m. to 11:45 a.m. CDT. He will present information that will help medical device manufacturers understand sterility assurance and bioburden data.
"I will discuss the necessity of a 10-6 sterility level, and will address the use of necessary levels of bioburden data to ensure proper sterilization," Winters says. "My presentation will be especially applicable to sterilization of combination products, biologics, and tissues."
In addition to the Learning Lab, Winters will present at the Tech Theater on May 7 from 1 p.m. to 1:30 p.m. His presentation will be "Updates to the Bioburden Standard ISO 11737-1: Significant Additional Guidance- P.S. What Happened to the Microbiologists?"
To register, CLICK HERE.
Source: Nelson Laboratories
How Cleaning Medical Equipment Directly Affects Patient Safety and Equipment Longevity
September 16th 2024Hospital-associated infections affect over 1 million US patients annually. Proper medical equipment cleaning and sterilization significantly reduce infection risks, improving patient outcomes and safety.
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Addressing Sterile Processing Instrument Errors With Advanced Technology and Data Insights
September 3rd 2024Surgical instrument errors, often linked to visualization failures during sterile processing, pose significant risks to patient safety and OR efficiency. Advanced technologies, including AI, are essential for reducing these errors and improving overall outcomes in sterile processing departments.
Implementing FDA 21 CFR Part 820 & ISO 13485 on Quality System Regulation
August 30th 2024The FDA's 21 CFR Part 820 and ISO 13485 are crucial in regulating medical device quality systems. Harmonizing these standards by 2026 will streamline compliance, improve patient access to devices, and align US regulations with global practices.
